Base Formation · 2026-06-25 · Pharmaceuticals & Drugs

GLAND

Gland Pharma Ltd.

Strong momentum structure

Early Trend
Stage 2 RS leader VCP active Handle

Setup readiness

Early Trend

Pivot Levels
₹2346.6-2408.0
Support Level
₹2239.0
Resistance
₹2875.2
Risk Distance
7.0% to stop

Reference levels for educational study only. Not a recommendation to buy or sell.

RS
82.0
ADX
33.0
Vol
15.0

Swing Edge Intelligence

Structured setup analysis · research only

Setup status · Constructive setup

Structure shows workable momentum characteristics with selective risks to monitor.

Relative strength Strong
Breakout readiness High
Accumulation Constructive

Bullish factors

  • MACD below zero — weak trend (−2).
  • Volume quality 15 very weak (-10).
  • Price is approaching the pivot zone.
  • 2 prior pivot rejections in last 60d (-16 pts).
  • ATR 3.6%/day — healthy volatility (+4).
  • Action-ready zone: RS and pivot distance aligned (+5).
  • BB squeeze — energy building.
  • Pivot type: flat-top — premium structure.
  • Recent volume expansion — institutional participation may be returning.
  • Volume flow suggests quiet institutional accumulation.
  • Volume persistence 1/3 — capped at Strong.

Risk factors

Overall view

Short-term accumulation is visible, though it should be weighed against trend and RS context. Leadership metrics are generally constructive, but select risk factors below deserve attention.

Size this trade

Setup research

GLAND — trend, RS & risk snapshot (not a trade recommendation)

Signal · context · invalidation · risk · skip reasons — research only

Positives

Coiled at the pivot — breakout trigger is imminent

  • RS line at new highs — leadership intact
  • Handle formed after the prior advance
  • Confirmed Stage 2 uptrend

Flagged today

Context & regime

  • Market regime Mixed / range-bound
  • Trend stage Stage 2 — tradable
  • Sector Mid-pack (#20/40)
  • Relative strength Leader (RS 82)
  • Trend strength Strong (ADX 33)

Negatives

This idea is wrong below ₹2239.0 (3.3% away)

Base / stop support breaks — the swing thesis is wrong below here

  • Stop / base low₹2239.0
  • Pivot — failure re-entry below₹2396.0

Risk distance

7.0% to stop
1.9× ATR
2.8× R:R
19.4% reward

Risk ≈ ₹168.97/share from entry ₹2408.0.

No major skip flags detected from current scanner data.

Setup metrics Base Formation

GLAND Technical Analysis & Swing Setup

Grouped structure, momentum and risk from the latest base formation scan.

Volume Profile bullish
POC₹2200.61
VAH₹2358.42
VAL₹2140.48
Vol above POC59.8%
Institutional Activity — Neutral
Avg cost basis₹2175.76
Acc zone₹1587.7–2370.0
Accumulation Sessions8
CMF-0.12

Structure

Trend / stage
Stage 2
Stage 2
Weekly trend
Above rising 30-wk MA
Uptrend
RS rank
82.0
Strong
ADX
33.0
Strong

Momentum

RSI
62.0
Strong
Recent move (10d / 20d)
+0.4% / +0.1%
Neutral
Volume quality
15.0
Thin
Relative strength
Leading
Leader

Risk

Failure risk
0.0
Low risk
ATR % / day
3.6%
Healthy
Distribution
1 day(s)
Neutral
Volatility
2 VCP
Contracting
More scanner fields
Sector RS 0.0%
Base 16w · 34.3%
VCP waves 2x
Vol dry-up No
Avg value ₹145.8 Cr
Failure flags None

GLAND Support & Resistance Levels

AI insights

AI Insights

Generated with AI

These insights are AI-generated to support your research process and should not be treated as investment advice or a recommendation to buy or sell securities.

Sign in to unlock AI Insights

Personalised swing trade analysis powered by Gemini AI

Pattern context 52w · setup · flow

52-week range

Stage-2 ideal band  ·  Early recovery

Pattern highlights

Loading…

Pattern signals from the latest scan

Smart money flow

Last 60 sessions · accumulation vs distribution

Loading…
Session flow 60 trading days
OBV trend On-balance volume · same window
·
Accumulation Distribution Neutral
Setup intelligence Overhead · VCP · radar · risk

Overhead supply

Resistance ceiling above current price

Loading…

Chase / failure risk

Honest read on exhaustion & extended moves

Loading…

Base / VCP coil

Depth, contractions & pivot distance

Loading…

Setup quality radar

Shape of the setup in one view

Loading…
Peer comparison Sector peers

Sector Peer Comparison

Loading sector peers…

Fetching peer data…
GLAND FAQ Common swing-trading questions

Frequently asked questions about GLAND

What are the screener observations for GLAND?

On Swing Edge's swing-setup framework, Gland Pharma Ltd. (GLAND) currently grades A — high-quality setup. Coiled at the pivot — breakout trigger is imminent. Flagged today. This is educational research, not investment advice.

What are GLAND's support and resistance levels?

For GLAND, near-term support sits around ₹2,239.0 (the base/stop zone); overhead resistance is around ₹2,396.0 (the breakout pivot); the next resistance above is ₹2,875.2. This is educational research, not investment advice.

What is the breakout / pivot level for GLAND?

The breakout pivot for GLAND is around ₹2,396.0. Price is about 3.4% below the pivot and still building toward it. A breakout is typically confirmed on a close above the pivot with above-average volume. This is educational research, not investment advice.

Is GLAND above its 50-day and 200-day moving averages?

Yes — GLAND is in a confirmed Stage 2 uptrend, trading above its rising 50- and 200-day moving averages, the zone where swing setups tend to work best. This is educational research, not investment advice.

How strong is GLAND versus the market (RS rank)?

GLAND has a relative strength (RS) rank of 82 out of 100 versus the NSE universe, making it a market leader — stronger than most NSE stocks. Trend strength (ADX) reads 33, indicating a strong trend. This is educational research, not investment advice.

Answers are generated from Swing Edge's latest scan data and are for research only — not investment advice.

Prices and day-change figures use the last daily close from scan data dated 2026-06-25 — not live intraday NSE quotes.